Efficacy of zonisamide in a case of Parkinson's disease with intractable resting and re-emergent tremor

European Journal of Neurology

Volumn 18, Issue 4, 2011, Pages

  Iijima, M ^a   Osawa, M ^a   Kobayashi, M ^a   Uchiyama, S ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Parkinson's disease; Re emergent tremor; Resting tremor; Zonisamide

Indexed keywords

AMANTADINE; CABERGOLINE; CARBIDOPA PLUS LEVODOPA; PRAMIPEXOLE; TRIHEXYPHENIDYL; ZONISAMIDE;

ADD ON THERAPY; ADL DISABILITY; AGED; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; ELECTROMYOGRAPHY; FEMALE; HAND TREMOR; HUMAN; JAW TREMOR; LETTER; LIMB TREMOR; PARKINSON DISEASE; PRIORITY JOURNAL; SOMNOLENCE; TONGUE TREMOR; TREMOR;

AGED; ANTIPARKINSON AGENTS; ELECTROMYOGRAPHY; FEMALE; HUMANS; ISOXAZOLES; PARKINSON DISEASE; RECURRENCE; REST; TREMOR;

EID: 79952724427     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03276.x     Document Type: Letter

References (15)

1. Murata M, Horiuchi E, Kanazawa I. Zonisamide has beneficial effects on Parkinson's disease patients. Neurosci Res 2001; 41: 397-399.
2. Murata M. Nobel therapeutic effects of the anti-convulsant, zonisamide on Parkinson's disease. Curr Pharm Des 2004; 10: 687-693.
3. Murata M, Hasegawa K, Kanazawa I; The Japan Zonisamide on PD Study Group. Zonisamide improves motor function in Parkinson's disease: a randomized, double-blind study. Neurology 2007;68:45-50.
4. Gluck MR, Santana LA, Granson H, et al. Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson's activity. J Neural Transm 2004; 111: 713-724.
5. Nakanishi I, Kohmoto J, Miwa H, et al. Effect of zonisamide on resting tremor resistant to antiparkinsonian medication. No to Shinkei 2003; 55: 685-689.
6. Bermejo PE. Zonisamide in patients with essential tremor and Parkinson's disease. Mov Disord 2007; 22: 2137-2138.
7. Morita S, Miwa H, Kondo T. Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol. Parkinsonism Related Disord 2005; 11: 101-103.
8. Ondo WG. Essential tremor: treatment options. Curr Treat Opt Neurol 2006; 8: 256-267.
9. Zesiewicz TA, Ward CL, Hauser RA, et al. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor. Mov Disord 2007; 22: 279-282.
10. Miwa H, Hama H, Kajimoto Y, et al. Effects of zonisamide on experimental tremors in rats. Parkinsonism Relat Disord 2008; 14: 33-36.
11. Miwa H, Kubo T, Suzuki A, et al. Effects of zonisamide on c-Fos expression under conditions of tacrine-induced tremulous jaw movements in rats: a potential mechanism underlying its anti-parkinsonian tremor effect. Parkinsonism Relat Disord 2009; 15: 30-35.
12. Jankovic J, Schwartz KS, Ondo W. Re-emergent tremor of Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67: 646-650.
13. Okada M, Kaneko S, Hirano T, et al. Effects of zonisamide on dopaminergic system. Epilepsy Res 1995; 22: 193-205.
14. Okada M, Kaneko S, Hirano T, et al. Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2+ dependent dopamine release. Epilepsy Res 1992; 13: 113-119.
15. Asanuma M, Miyazaki I, Diaz-Corrales FJ, et al. Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinine formation. Neurosci Res 2008; 60: 106-113.